Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    17429083 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Treatment of Patients With Type 2 Diabetes With an Interleukin-1 Antagonist
Condition: Type 2 Diabetes
Intervention: Drug: IL-1Ra
2 Recruiting Evaluation of a Stepped Care Approach to Manage Depression in Diabetes
Conditions: Major Depressive Disorder;   Minor Depressive Disorder;   Sub-Threshold Depression;   Diabetes Mellitus
Interventions: Behavioral: Step 1: Diabetes-Specific CBT (5 group sessions);   Behavioral: Step 2: Depression-Specific CBT (6 single sessions);   Behavioral: Step 3: Referral to Psychotherapist and/or Psychiatrist;   Behavioral: Standard Diabetes Education
3 Recruiting Anti-IL-1 Treatment in Children DKA at Diagnosis of Type 1 Diabetes
Condition: Type I Diabetes
Interventions: Drug: Anakinra;   Other: Placebo Comparator
4 Unknown  Interleukin-1 Receptor Antagonist and Insulin Sensitivity
Conditions: Diabetes Mellitus, Type 2;   Insulin Resistance
Interventions: Drug: Anakinra (Kineret);   Drug: Placebo

Indicates status has not been verified in more than two years